NICHOLAS BOLOGNA: Open Payments
NPI 1467183590 · TERRYTOWN, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$421 in 21 payments from 7 companies in 2025. Trend: 2023 $19 · 2024 $296 · 2025 $421
Food & beverage: $397Education: $24
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $135 |
| Vanda Pharmaceuticals Inc. | 5 | $115 |
| ABBVIE INC. | 3 | $74 |
| Axsome Therapeutics, Inc. | 2 | $40 |
| Lundbeck LLC | 1 | $21 |
| ACADIA Pharmaceuticals Inc | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
Products named: CAPLYTA, FANAPT, VRAYLAR, Auvelity, ABILIFY ASIMTUFII, NUPLAZID.
Industry payments across LA — which companies pay providers there.
